|
Esteve-Pastor MA, Rivera-Caravaca JM, Shantsila A, Roldán V, Lip GYH, Marín F. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial. Thromb Haemost. 2017 Dec;117(12):2261-2266. doi: 10.1160/TH17-10-0710. Epub 2017 Dec 6. PubMed PMID: 29212113.
AÑO: 2017; IF: 4.952
|
29212113
|
García-Fernández A, Roldán V, Marín F. Strategies for prediction and early detection of atrial fibrillation: present and future. Europace. 2017 Apr 1;19(4):515-517. doi: 10.1093/europace/euw131. PubMed PMID: 28431067.
AÑO: 2017; IF: 5.231
|
|
Esteve-Pastor MA, García-Fernández A, Roldán V, Marín F. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27. English, Spanish. PubMed PMID: 28034682.
AÑO: 2017; IF: 5.166
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. Sci Rep. 2017 Sep 21;7(1):12066. doi: 10.1038/s41598-017-11683-2. PubMed PMID: 28935868; PubMed Central PMCID: PMC5608893.
AÑO: 2017; IF: 4.122
|
|
Roldán V, Marín F. Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision making. Thromb Haemost. 2017 Apr 3;117(4):647-649. doi: 10.1160/TH17-02-0131. Epub 2017 Mar 9. PubMed PMID: 28276568.
AÑO: 2017; IF: 6.681
|